Found: 255
Select item for more details and to access through your institution.
Multicancer Early Detection Blood Test May Change Screening Paradigm.
- Published in:
- Value-Based Cancer Care, 2022, v. 13, n. 6, p. 1
- By:
- Publication type:
- Article
Improving Diversity in Clinical Trials.
- Published in:
- Oncology Practice Management, 2023, v. 13, n. 9, p. 1
- By:
- Publication type:
- Article
Final Analysis of KEYNOTE-826 Trial Confirms Benefit of Pembrolizumab Plus Chemotherapy in First-Line Treatment of Cervical Cancer.
- Published in:
- Oncology Practice Management, 2023, v. 13, n. 8, p. 18
- By:
- Publication type:
- Article
Ribociclib Plus Adjuvant Endocrine Therapy Reduces Risk for Recurrence in HR-Positive, HER2-Negative, Early Breast Cancer.
- Published in:
- Oncology Practice Management, 2023, v. 13, n. 7, p. 12
- By:
- Publication type:
- Article
Partnering With Patients to Improve Healthcare Outcomes.
- Published in:
- Oncology Practice Management, 2023, v. 13, n. 7, p. 1
- By:
- Publication type:
- Article
mRNA Vaccine Plus Immunotherapy Shows Promise in Melanoma.
- Published in:
- Oncology Practice Management, 2023, v. 13, n. 6, p. 1
- By:
- Publication type:
- Article
Study Highlights Need to Raise Awareness of Link Between HPV and Cancer.
- Published in:
- Oncology Practice Management, 2023, v. 13, n. 5, p. 1
- By:
- Publication type:
- Article
Young Women with Breast Cancer May Safely Pause Endocrine Therapy to Pursue Pregnancy.
- Published in:
- Oncology Practice Management, 2023, v. 13, n. 3, p. 14
- By:
- Publication type:
- Article
Use of Ibrutinib May Replace ASCT in Mantle-Cell Lymphoma.
- Published in:
- Oncology Practice Management, 2023, v. 13, n. 2, p. 1
- By:
- Publication type:
- Article
New Evidence Shows How Air Pollution May Contribute to Lung Cancer in Never-Smokers.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 10, p. 8
- By:
- Publication type:
- Article
Zanubrutinib Outperforms Ibrutinib in Relapsed or Refractory CLL/SLL.
- Published in:
- Oncology Practice Management, 2023, v. 13, n. 1, p. 7
- By:
- Publication type:
- Article
Restrictive Diet May Be Unnecessary in Patients Undergoing HSCT.
- Published in:
- Oncology Practice Management, 2023, v. 13, n. 1, p. 1
- By:
- Publication type:
- Article
Improved Overall Survival with First-Line Brentuximab Vedotin plus AVD in Patients with Advanced Hodgkin Lymphoma: Results from the ECHELON-1 Trial.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 12, p. 16
- By:
- Publication type:
- Article
Adding Radiation to Systemic Therapy Improves Survival in Patients with Advanced Hepatocellular Cancer.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 12, p. 9
- By:
- Publication type:
- Article
Shortened Radiation Schedule Safe and Effective in High-Risk Prostate Cancer.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 12, p. 7
- By:
- Publication type:
- Article
Female Patients Undergoing Cancer Treatment Rarely Asked About Sexual Health.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 12, p. 1
- By:
- Publication type:
- Article
Understanding the Evolving Landscape for the Diagnosis and Treatment of AML.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 12, p. 1
- By:
- Publication type:
- Article
Early Detection Blood Test May Change Cancer Screening Paradigms.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 11, p. 9
- By:
- Publication type:
- Article
Integrating Digital Health Technology into Cancer Care.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 10, p. 1
- By:
- Publication type:
- Article
New Survey Reveals Physicians' Attitudes Toward Biosimilars.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 10, p. 17
- By:
- Publication type:
- Article
Nirogacestat Significantly Improves Progression-Free Survival in Patients with Desmoid Tumors.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 10, p. 7
- By:
- Publication type:
- Article
Patients Aged ≥55 Years with Luminal A Breast Cancer Can Safely Avoid Radiation.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 9, p. 18
- By:
- Publication type:
- Article
Adding a Bispecific Antibody to Natural Killer Cells May Be Effective in Relapsed or Refractory CD30-Positive Lymphoma.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 9, p. 12
- By:
- Publication type:
- Article
Acalabrutinib Shows Promise in Patients with Marginal Zone Lymphoma.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 7, p. 10
- By:
- Publication type:
- Article
Neoadjuvant Chemoimmunotherapy Shows Promise in Advanced Ovarian Cancer.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 9, p. 11
- By:
- Publication type:
- Article
Adjuvant Pembrolizumab Maintains DFS Benefit in Patients with High-Risk RCC.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 1, p. 19
- By:
- Publication type:
- Article
"One Size Does Not Fit All" in Newly Diagnosed Multiple Myeloma.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 9, p. 1
- By:
- Publication type:
- Article
Black Patients with Cancer and COVID-19 More Likely to Have Treatment Disruptions Than White Patients.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 8, p. 9
- By:
- Publication type:
- Article
Neoadjuvant Chemoimmunotherapy May Become New Standard of Care for Patients with Resectable NSCLC.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 7, p. 18
- By:
- Publication type:
- Article
Dostarlimab Demonstrates 100% Complete Response Rate in Subset of Patients with dMMR Rectal Cancer.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 7, p. 8
- By:
- Publication type:
- Article
Niraparib plus Abiraterone Combination Extends PFS in Men with CRPC and HRR Gene Mutations.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 7, p. 1
- By:
- Publication type:
- Article
First-Line Treatment with Olaparib plus Abiraterone Improves Outcomes in Patients with CRPC Regardless of HRR Mutational Status.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 1, p. 17
- By:
- Publication type:
- Article
Genetic Score Makes PSA Screening More Accurate.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 1, p. 8
- By:
- Publication type:
- Article
Collaboration Among Oncologists and Primary Care Physicians Is Key to Closing the “Black Hole” in Cancer Survivorship Care.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 1, p. 7
- By:
- Publication type:
- Article
Sotorasib Shows Long-Term Efficacy in Metastatic NSCLC with KRAS Mutation.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 1, p. 1
- By:
- Publication type:
- Article
New COVID-19 Vaccine Focused on T-Cell Response Shows Promise in Patients with Cancer.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 5, p. 1
- By:
- Publication type:
- Article
Sacituzumab plus Pembrolizumab Shows Encouraging Antitumor Activity in Metastatic Urothelial Cancer.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 5, p. 1
- By:
- Publication type:
- Article
Study Finds 1 in 6 Patients with Cancer Experience "Long-Haul" COVID-19.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 4, p. 15
- By:
- Publication type:
- Article
Adding Ivosidenib to First-Line Azacitidine Improves Outcomes in Older Patients with AML.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 3, p. 14
- By:
- Publication type:
- Article
Elacestrant May Improve Outcomes for Patients with Metastatic Breast Cancer Who Have Progressed on Previous Endocrine Therapy.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 3, p. 1
- By:
- Publication type:
- Article
Isatuximab plus RVd Regimen Achieves Highest Rates of No MRD in Patients with Multiple Myeloma.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 3, p. 1
- By:
- Publication type:
- Article
Time-Limited Venetoclax-Based Combinations Show Efficacy in Fit Patients with Chronic Lymphocytic Leukemia.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 2, p. 17
- By:
- Publication type:
- Article
Polatuzumab Vedotin plus R-CHP Beats Standard R-CHOP for Frontline Treatment of DLBCL.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 2, p. 1
- By:
- Publication type:
- Article
Abiraterone Added to ADT Improves Survival in Patients with High-Risk Prostate Cancer.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 1, p. 29
- By:
- Publication type:
- Article
Adagrasib Shows Encouraging Activity in Select Patients with Metastatic Colorectal Cancer.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 1, p. 28
- By:
- Publication type:
- Article
Trastuzumab Deruxtecan Shows Promise in Controlling Stable Brain Metastases in HER2-Positive Breast Cancer.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 1, p. 1
- By:
- Publication type:
- Article
Antibody-Drug Conjugate Shows Promising Activity in Advanced or Metastatic EGFR Mutation-Positive NSCLC.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 12, p. 28
- By:
- Publication type:
- Article
ALK-Targeted Therapy May Be Benefcial in Adult-Onset Neuroblastoma.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 11, p. 33
- By:
- Publication type:
- Article
Amivantamab plus Lazertinib Combination Shows Promise in Osimertinib-Resistant EGFR-Positive NSCLC.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 11, p. 14
- By:
- Publication type:
- Article
Neoadjuvant Nivolumab plus Chemotherapy Significantly Improves Pathologic Complete Response in Patients with Resectable NSCLC.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 9, p. 17
- By:
- Publication type:
- Article